Active Ingredient: APIXABAN
Proprietary Name: ELIQUIS
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N202155
Product Number: 001
Approval Date: Dec 28, 2012
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE
Marketing Status:
Prescription
Patent and Exclusivity Information
